drugset / Trial / NCT03120247
Pharmacokinetics and Pharmacodynamics of Oral Transmucosal Dexmedetomidine.
RandomizedParallel-groupDouble-blindTreatment
Summary
Oral trans-mucosal administration is relatively easy and convenient, it also reduces first pass metabolism and has been used successfully for fentanyl, ketamine, and midazolam premedication.
Timeline
- Start
- 2017-04-05
- Primary completion
- 2019-06-01
- Completion
- 2019-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexmedetomidine | Other / unclassified | 0.5 ug/kg | Oral |
| Comparator | Dexmedetomidine | Other / unclassified | 0.75 ug/kg | Oral |
| Comparator | Dexmedetomidine | Other / unclassified | 1 ug/kg | Oral |
Indications
No indication recorded.